Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 2409471, 11 pages
https://doi.org/10.1155/2018/2409471
Research Article

Zuo Gui Wan Alters Expression of Energy Metabolism Genes and Prevents Cell Death in High-Glucose Loaded Mouse Embryos

1Shanxi University of Chinese Medicine, Taiyuan 030619, China
2School of Biological Sciences, University of Adelaide, Adelaide, SA 5005, Australia
3Beijing University of Chinese Medicine, Beijing 100029, China

Correspondence should be addressed to Qiang Song; moc.361@44884643831 and David L. Adelson; ua.ude.edialeda@nosleda.divad

Received 7 December 2017; Revised 15 March 2018; Accepted 3 April 2018; Published 25 June 2018

Academic Editor: Mohammed S. Razzaque

Copyright © 2018 Qi Liang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Bindea, B. Mlecnik, H. Hackl et al., “ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks,” Bioinformatics, vol. 25, no. 8, pp. 1091–1093, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. J. Grant, A. Bensoussan, D. Chang, H. Kiat, N. L. Klupp, J. P. Liu et al., “Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose,” The Cochrane Database of Systematic Reviews, Article ID CD006690, 2009. View at Google Scholar
  3. E. S. Ford, G. Zhao, and C. Li, “Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence,” Journal of the American College of Cardiology, vol. 55, no. 13, pp. 1310–1317, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. Q. Jia, H. Zheng, X. Zhao et al., “Abnormal glucose regulation in patients with acute stroke across China: Prevalence and baseline patient characteristics,” Stroke, vol. 43, no. 3, pp. 650–657, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Karasik, “Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum,” Annals of Medicine, vol. 37, no. 4, pp. 250–258, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Alssema, J. M. Dekker, G. Nijpels, C. D. A. Stehouwer, L. M. Bouter, and R. J. Heine, “Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality: An 11-year follow-up of the Hoorn study,” Diabetes Care, vol. 28, no. 4, pp. 860–865, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. Y.-X. Meng, E. S. Ford, C. Li et al., “Association of C-reactive protein with surrogate measures of insulin resistance among nondiabetic US from National Health and Nutrition Examination Survey 1999–2002,” Clinical Chemistry, vol. 53, no. 12, pp. 2152–2159, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. E. Vermeer, W. Sandee, A. Algra, P. J. Koudstaal, L. J. Kappelle, and D. W. J. Dippel, “Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke,” Stroke, vol. 37, no. 6, pp. 1413–1417, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. M. Gabir, R. L. Hanson, D. Dabelea et al., “Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabets,” Diabetes Care, vol. 23, no. 8, pp. 1113–1118, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Mori, K. Hoshino, K. Yokota, T. Yokose, and N. Tajima, “Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men,” Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association, vol. 113, no. 6, pp. 334–339, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Basturk and A. Unsal, “What is the frequency of carbohydrate metabolism disorder in CKD?” Journal of Renal Care, vol. 38, no. 1, pp. 15–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. I. Kim, C.-H. Kim, C. S. Choi et al., “Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population,” Diabetes Research and Clinical Practice, vol. 52, no. 2, pp. 145–152, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. A. H. Xiang, R. K. Peters, S. L. Kjos et al., “Effect of pioglitazone on pancreatic β-cell function and diabetes risk in Hispanic women with prior gestational diabetes,” Diabetes, vol. 55, no. 2, pp. 517–522, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J.-L. Chiasson, R. G. Josse, R. Gomis, M. Hanefeld, A. Karasik, and M. Laakso, “Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial,” The Lancet, vol. 359, no. 9323, pp. 2072–2077, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. W. C. Knowler, E. Barrett-Connor, S. E. Fowler et al., “Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin,” The New England Journal of Medicine, vol. 346, no. 6, pp. 393–403, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. Investigators TDT, “Effect of ramipril on the incidence of diabetes,” The New England Journal of Medicine, vol. 35, no. 15, pp. 1551–1562, 2006. View at Google Scholar
  17. A. J. Scheen, “Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s,” Drugs, vol. 54, pp. 355–368, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. S. E. Nissen and K. Wolski, “Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes,” The New England Journal of Medicine, vol. 356, no. 24, pp. 2457–2471, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. H. J. H. Ai-zhen, L. Zhe-Feng, and C. Yuan, “Observation of clinical efficacy of Xiao-ke-hua-Yu-pian on impaired glucose tolerance,” Medical Journal of Chinese People’s Liberation Army, vol. 29, pp. 993-994, 2004. View at Google Scholar
  20. P. Shan-Yu, “Prevention and treating impaired glucose tolerance with Traditional Chinese Medicine,” ZheJiang Journal of Integrated Traditional Chinese and Western Medicine, vol. 16, article 354, 2006. View at Google Scholar
  21. D.-H. D.-B. Wang and Z. Qi, “Observation of clinical efficacy of Traditional Chinese medicine on impaired glucose tolerance,” Journal of Si Chuan of Traditional Chinese Medicine, vol. 24, pp. 63-64, 2006. View at Google Scholar
  22. X. Z. Wang, “Traditional Chinese medicine experience of professor TONG Xiao-lin in the treatment of steroid diabetes,” Chinese Archives of Traditional Chinese Medicine, vol. 23, pp. 1764-1765, 2005. View at Google Scholar
  23. W.-Q. W.-H. Yu, “Observation of clinical efficacy of Jia-Wei-Yu-Ye-Tang on impaired glucose tolerance,” Journal of ZheJiang University of Traditional Chinese Medicine, vol. 33, pp. 402-403, 2009. View at Google Scholar
  24. W. Yue-Xin, “Preventive effect of Jin-qi-jiang-tang-pian on impaired glucose tolerance,” TianJin Medicial Journal, vol. 33, pp. 793-794, 2005. View at Google Scholar
  25. H. Shu-Ling, H. Shu-Fang, M. Ming, and Z. Yu-Qing, “Observation of Clinical Therapeutic Effects of Xiaodan Decoction on 32 Cases of Impaired Glucose Tolerance,” World Journal of Integrated Traditional and Western Medicine, vol. 2, article 016, 2009. View at Google Scholar
  26. X. Kai-Xia, Experimental study on preventive effect of tonifying kidney formulas fed during embryonic period on offspring rats’ IGT which induced by high-fat diet Beijing University of Traditional Chinese Medicine, 2012.
  27. Y. Wang, Q. Feng, X. Niu et al., “The preventive effect of Zuogui wan on offspring rats' impaired glucose tolerance whose mothers had gestational diabetes mellitus,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 9417362, 8 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Xu, J. Shen, H. Liu, Y. Shi, H. Li, and M. Wei, “Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress,” Canadian Journal of Physiology and Pharmacology, vol. 84, no. 12, pp. 1267–1273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Y. Chen and Y. C. Chen, “A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention,” Food Chemistry, vol. 138, no. 4, pp. 2099–2107, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. Q. J. Feng, M. L. Feng, and Y. L. Wang, “Effect of zuoguiwan on early embryonic development of mice,” Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi= Chinese journal of integrated traditional and Western medicine/Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban, vol. 16, no. 11, pp. 673–675, 1996. View at Google Scholar · View at Scopus
  31. A. Dobin, C. A. Davis, F. Schlesinger et al., “STAR: ultrafast universal RNA-seq aligner,” Bioinformatics, vol. 29, no. 1, pp. 15–21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Lawrence, W. Huber, H. Pags, P. Aboyoun, and M. Carlson, “Software for computing and annotating genomic ranges,” PLoS Computational Biology, vol. 9, no. 8, Article ID e1003118, 2013. View at Publisher · View at Google Scholar
  33. M. I. Love, W. Huber, and S. Anders, “Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2,” Genome Biology, vol. 15, no. 12, article 550, 2014. View at Publisher · View at Google Scholar
  34. P. Shannon, A. Markiel, O. Ozier et al., “Cytoscape: a software Environment for integrated models of biomolecular interaction networks,” Genome Research, vol. 13, no. 11, pp. 2498–2504, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. K. H. Moley, W. K. Vaughn, A. H. DeCherney, and M. P. Diamond, “Effect of diabetes mellitus on mouse pre-implantation embryo development,” Journal of Reproduction and Fertility, vol. 93, no. 2, pp. 325–332, 1991. View at Publisher · View at Google Scholar · View at Scopus
  36. X.-M. Z.-Y. Luo, F. Yin, Y. Chen et al., “The effect of hyperglycemia on early mouse embryo development,” Life Science Research, vol. 12, pp. 347–350, 2008. View at Google Scholar
  37. Z. Hong, Study on relationship between reactive oxygen, p66~(shc) and development block of mouse embryos induced by high glucose, Zhengzhou University, 2013.
  38. L. Zhang, Z.-S. Li, and N.-Z. Fang, “Glucose-induced ROS inhibits mouse early embryo development at late 2-cell stage in vitro,” Academic Journal of Second Military Medical University, vol. 30, no. 8, pp. 888–891, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. K. D. Taylor and L. Pikó, “Expression of ribosomal protein genes in mouse oocytes and early embryos,” Molecular Reproduction and Development, vol. 31, no. 3, pp. 182–188, 1992. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Li-Li, Epigenetics research of abnormal glucose metabolism in uterus, Peking Union Medical College, 2011.
  41. C. E. H. Stewart and P. Rotwein, “Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors,” Physiological Reviews, vol. 76, no. 4, pp. 1005–1026, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. V. Rouiller-Fabre, L. Lecerf, C. Gautier, J. M. Saez, and R. Habert, “Expression and effect of insulin-like growth factor I on rat fetal Leydig cell function and differentiation,” Endocrinology, vol. 139, no. 6, pp. 2926–2934, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. L. P. Liu, Y. L. Ren, and R. Li, “Effects of p38 signal pathway on osteoblastic cell differentiation by Zuogui pill medicated serum in MC3T3-E1 cell,” Chinese Journal of Gerontology, vol. 7, article 042, 2013. View at Google Scholar
  44. C.-Y. Hao, Y.-L. Ren, and J.-R. Zhao, “Effects of Zuogui pill medicated serum via ERK/samds dependent pathway on MC3T3-E1 cell gene expression,” Chinese Pharmacological Bulletin, vol. 28, no. 6, pp. 872–876, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. Z.-B. X.-C. Gong and G.-Q. Jin, “The study of modulating effect of zuogui pill on rat thymocytes apoptosis and expression of Bcl-2 and Bax,” Chinese Journal of Gerontology, vol. 30, pp. 3290–3292, 2010. View at Google Scholar
  46. X.-F. Sun, L. Luo, Q.-C. Sun et al., “Experimental study of zuogui pills in stimulation of mouse immature oocytes nuclear maturation in vitro,” Progress in Modern Biomedicine, vol. 3, article 015, 2011. View at Google Scholar